Exicure, Inc.

Exicure, Inc. Website Screenshot


Exicure, Inc. Company Intro

Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for immuno-oncology, genetic disorders, and other indications. Its three clinical programs include AST-008, which is in a Phase I clinical trial, an SNA consisting of toll-like receptor 9 that is designed for immuno-oncology applications; XCUR17, which is in a Phase I clinical trial, an SNA that targets the messenger RNA (mRNA) encoding interleukin 17 receptor alpha, a protein that helps in the initiation and maintenance of psoriasis; and AST-005, which is in a Phase I clinical trial, an SNA that targets TNF for the treatment of mild to moderate psoriasis. Exicure, Inc. has collaboration agreements with Allergan plc; DERMELIX, LLC; and Purdue Pharma L.P. The company was founded in 2011 and is headquartered in Skokie, Illinois.



Exicure, Inc. Headquaters

8045 Lamon Avenue
United States

Exicure, Inc. Share price

17 May 2023 14:08 GMT


-0.0 (-0.26 %)

Exicure, Inc. Market cap

$9.078 M



Exicure, Inc. # 150


Latest Exicure, Inc. News

News 28 Nov 2023

Press release distribution, EDGAR filing, XBRL, regulatory filings

NEW YORK--( BUSINESS WIRE)--G-III Apparel Group, Ltd. (NASDAQ: GIII) a global leader in fashion with expertise in design, sourcing, and manufacturing,...

News 28 Nov 2023

Exicure receives Nasdaq delinquency notice on late filing of its form 10-Q (NASDAQ:XCUR)

Exicure (XCUR) receives notice of non-compliance from Nasdaq over late filing of quarterly report, has 60 days to submit a plan for regaining compliance.

WMC Market Score

WMC Market to Revenue Score

Exicure, Inc. Market Financials

Revenue, Expenses, Profit

Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Exicure, Inc. USD $8,427 $46,554 $-38,295 $91M 150
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $804,390B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $878,880B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $144,340B 4

Market Analytics

Company Search vs Top 4 Industry Competitors

Total Exicure, Inc. Social Followers vs Top 4 Industry Competitors

Exicure, Inc. Post vs Top 4 Industry Competitors

Exicure, Inc. Digital Footprint By Size vs Top 4 Industry Competitors

Exicure, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors

Exicure, Inc. WMC Market Score Calculations

Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Exicure, Inc. 0.09 0 0 0 0 0 0
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 28 0 0 29.94
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 40 0 0 36.32
Alexion Pharmaceuticals, Inc. 68.08 100 100 32 0 0 100
Incyte Corporation 29.39 5.03 0.04 100 0 0 45.31

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb